Neutrophil release of myeloperoxidase in systemic vasculature of obese women may put them at risk for preeclampsia

Reproductive Sciences

Volumn 22, Issue 3, 2015, Pages 300-307

  Shukla, Juhi ^a   Walsh, Scott W ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

hypertension; myeloperoxidase; neutrophils; obesity; preeclampsia

Indexed keywords

MYELOPEROXIDASE; PROTEIN; BIOLOGICAL MARKER; PEROXIDASE;

ADULT; ARTICLE; BLOOD VESSEL WALL; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; GESTATIONAL AGE; HUMAN; IMMUNOHISTOCHEMISTRY; LEUKOCYTE; NEUTROPHIL CHEMOTAXIS; OBESITY; OPTICAL DENSITY; OXIDATIVE STRESS; PREECLAMPSIA; PREGNANT WOMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN URINE LEVEL; PROTEINURIA; RISK FACTOR; SYSTOLIC BLOOD PRESSURE; VASCULAR SMOOTH MUSCLE; BLOOD VESSEL; CASE CONTROL STUDY; COMPLICATION; ENZYMOLOGY; METABOLISM; NEUTROPHIL; PATHOPHYSIOLOGY; PRE-ECLAMPSIA; PREGNANCY; SUBCUTANEOUS FAT; UPREGULATION; VASCULARIZATION;

ADULT; BIOMARKERS; BLOOD VESSELS; CASE-CONTROL STUDIES; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; NEUTROPHIL INFILTRATION; NEUTROPHILS; OBESITY; PEROXIDASE; PRE-ECLAMPSIA; PREGNANCY; RISK FACTORS; SUBCUTANEOUS FAT; UP-REGULATION;

EID: 84924813651     PISSN: 19337191     EISSN: 19337205     Source Type: Journal    
DOI: 10.1177/1933719114557899     Document Type: Article

References (39)

1. Bodnar LM, Ness RB, Markovic N, Roberts JM. The risk of preeclampsia rises with increasing prepregnancy body mass index. Ann Epidemiol. 2005; 15 (7). 475-482
2. Eskenazi B, Fenster L, Sidney S. A multivariate analysis of risk factors for preeclampsia. JAMA. 1991; 266 (2). 237-241
3. Kabiru W, Raynor BD. Obstetric outcomes associated with increase in BMI category during pregnancy. Am J Obstet Gynecol. 2004; 191 (3). 928-932
4. Kumari AS. Pregnancy outcome in women with morbid obesity. Int J Gynaecol Obstet. 2001; 73 (2). 101-107
5. O'Brien TE, Ray JG, Chan WS. Maternal body mass index and the risk of preeclampsia: a systematic overview. Epidemiology. 2003; 14 (3). 368-374
6. Sibai BM, Ewell M, Levine RJ, et al. Risk factors associated with preeclampsia in healthy nulliparous women. The Calcium for Preeclampsia Prevention (CPEP) Study Group. Am J Obstet Gynecol. 1997; 177 (5). 1003-1010
7. Sibai BM, Gordon T, Thom E, et al. Risk factors for preeclampsia in healthy nulliparous women: a prospective multicenter study. The National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. Am J Obstet Gynecol. 1995; 172 (2 pt 1). 642-648
8. Stone JL, Lockwood CJ, Berkowitz GS, Alvarez M, Lapinski R, Berkowitz RL. Risk factors for severe preeclampsia. Obstet Gynecol. 1994; 83 (3). 357-361
9. Villamor E, Cnattingius S. Interpregnancy weight change and risk of adverse pregnancy outcomes: a population-based study. Lancet. 2006; 368 (9542). 1164-1170
10. Belogolovkin V, Eddleman KA, Malone FD, et al. The effect of low body mass index on the development of gestational hypertension and preeclampsia. J Matern Fetal Neonatal Med. 2007; 20 (7). 509-513
11. Catov JM, Ness RB, Kip KE, Olsen J. Risk of early or severe pre-eclampsia related to pre-existing conditions. Int J Epidemiol. 2007; 36 (2). 412-419
12. Eiserich JP, Baldus S, Brennan ML, et al. Myeloperoxidase, a leukocyte-derived vascular NO oxidase. Science. 2002; 296 (5577). 2391-2394
13. Nicholls SJ, Hazen SL. Myeloperoxidase and cardiovascular disease. Arterioscler Thromb Vasc Biol. 2005; 25 (6). 1102-1111
14. Schindhelm RK, van der Zwan LP, Teerlink T, Scheffer PG. Myeloperoxidase: a useful biomarker for cardiovascular disease risk stratification?. Clin Chem. 2009; 55 (8). 1462-1470
15. Walker AE, Seibert SM, Donato AJ, Pierce GL, Seals DR. Vascular endothelial function is related to white blood cell count and myeloperoxidase among healthy middle-aged and older adults. Hypertension. 2010; 55 (2). 363-369
16. Van der Zwan LP, Scheffer PG, Dekker JM, Stehouwer CD, Heine RJ, Teerlink T. Hyperglycemia and oxidative stress strengthen the association between myeloperoxidase and blood pressure. Hypertension. 2010; 55 (6). 1366-1372
17. Hubel CA. Oxidative stress in the pathogenesis of preeclampsia. Proc Soc Exp Biol Med. 1999; 222 (3). 222-235
18. Walsh SW. Maternal-placental interactions of oxidative stress and antioxidants in preeclampsia. Semin Reprod Endocrinol. 1998; 16 (1). 93-104
19. Walsh SW, Vaughan JE, Wang Y, Roberts LJ. Placental isoprostane is significantly increased in preeclampsia. FASEB J. 2000; 14 (10). 1289-1296
20. Gandley RE, Rohland J, Zhou Y, et al. Increased myeloperoxidase in the placenta and circulation of women with preeclampsia. Hypertension. 2008; 52 (2). 387-393
21. Veenstra van Nieuwenhoven AL, Bouman A, Moes H, et al. Cytokine production in natural killer cells and lymphocytes in pregnant women compared with women in the follicular phase of the ovarian cycle. Fertil Steril. 2002; 77 (5). 1032-1037
22. Lurie S, Frenkel E, Tuvbin Y. Comparison of the differential distribution of leukocytes in preeclampsia versus uncomplicated pregnancy. Gynecol Obstet Invest. 1998; 45 (4). 229-231
23. Leik CE, Walsh SW. Neutrophils infiltrate resistance-sized vessels of subcutaneous fat in women with preeclampsia. Hypertension. 2004; 44 (1). 72-77
24. Gervasi MT, Chaiworapongsa T, Pacora P, et al. Phenotypic and metabolic characteristics of monocytes and granulocytes in preeclampsia. Am J Obstet Gynecol. 2001; 185 (4). 792-797
25. Sacks GP, Studena K, Sargent K, Redman CW. Normal pregnancy and preeclampsia both produce inflammatory changes in peripheral blood leukocytes akin to those of sepsis. Am J Obstet Gynecol. 1998; 179 (1). 80-86
26. Cadden KA, Walsh SW. Neutrophils, but not lymphocytes or monocytes, infiltrate maternal systemic vasculature in women with preeclampsia. Hypertens Pregnancy. 2008; 27 (4). 396-405
27. Mishra N, Nugent WH, Mahavadi S, Walsh SW. Mechanisms of enhanced vascular reactivity in preeclampsia. Hypertension. 2011; 58 (5). 867-873
28. Shah TJ, Walsh SW. Activation of NF-kappaB and expression of COX-2 in association with neutrophil infiltration in systemic vascular tissue of women with preeclampsia. Am J Obstet Gynecol. 2007; 196 (1). 48.e1-48.e8
29. Mousa AA, Strauss JF, Walsh SW. Reduced methylation of the thromboxane synthase gene is correlated with its increased vascular expression in preeclampsia. Hypertension. 2012; 59 (6). 1249-1255
30. Walsh SW. Obesity: a risk factor for preeclampsia. Trends Endocrinol Metab. 2007; 18 (10). 365-370
31. Shah TJ, Leik CE, Walsh SW. Neutrophil infiltration and systemic vascular inflammation in obese women. Reprod Sci. 2010; 17 (2). 116-124
32. Cunningham FG, Leveno KJ, Bloom SL, Hauth JC, Gilstrap III LC, Wenstrom KD Williams Obstetrics. 22 nd ed. New York, NY: McGraw-Hill; 2005. New York, NY: McGraw-Hill; 2005 :
33. Baldus S, Eiserich JP, Mani A, et al. Endothelial transcytosis of myeloperoxidase confers specificity to vascular ECM proteins as targets of tyrosine nitration. J Clin Invest. 2001; 108 (12). 1759-1770
34. Klebanoff SJ. Myeloperoxidase: friend and foe. J Leukoc Biol. 2005; 77 (5). 598-625
35. Wang JA, Zhen EZ, Guo ZZ, Lu YC. Effect of hyperlipidemic serum on lipid peroxidation, synthesis of prostacyclin and thromboxane by cultured endothelial cells: protective effect of antioxidants. Free Radic Biol Med. 1989; 7 (3). 243-249
36. Warso MA, Lands WE. Lipid peroxidation in relation to prostacyclin and thromboxane physiology and pathophysiology. Br Med Bull. 1983; 39 (3). 277-280
37. Kulmacz RJ, Lands WEM. Requirements for hydroperoxide by the cyclooxygenase and peroxidase activities of prostaglandin H synthase. Prostaglandins. 1983; 25 (4). 531-540
38. Vaughan JE, Walsh SW. Neutrophils from pregnant women produce thromboxane and tumor necrosis factor-alpha in response to linoleic acid and oxidative stress. Am J Obstet Gynecol. 2005; 193 (3 pt 1). 830-835
39. Walsh SW, Wang Y, Jesse R. Peroxide induces vasoconstriction in the human placenta by stimulating thromboxane. Am J Obstet Gynecol. 1993; 169 (4). 1007-1012